When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - ADMA: Ready To Capitalize On The IVIG Shortage
ADMA Biologics Inc
Over the past few months, ADMA Biologics (ADMA) has been able to record several key accomplishments and milestones. During the second quarter, the company received FDA approval for both BIVIGAM and ASCENIV. In addition, the company now has product licenses for Nabi-HB and BIVIGAM. What is more, ADMA has executed an equity financing of about $52M which will support the launches of BIVIGAM and ASCENIV. The company also reported encouraging Q2 earnings with big beats on EPS and revenue. Recently, ADMA announced the relaunch of BIVIGAM after a long and arduous PAS review